Ficolin-2 triggers antitumor effect by activating macrophages and CD8+ T cells
Author:  Date:2017-10-01  Clicks:

Clin Immunol.2017 Oct;183:145-157. doi: 10.1016/j.clim.2017.08.012. Epub 2017 Aug 26.

Ficolin-2triggersantitumoreffectbyactivatingmacrophagesandCD8+Tcells.

Ding Q1,Shen Y1,Li D2,Yang J1,Yu J3,Yin Z4,Zhang XL5.

Author information

Abstract

Ficolin-2is an important serum complement lectin. Here, we describe novel findings indicating that serumficolin-2concentrations in multiple tumor patients are significantly lower than those in healthy donors. Administration of exogenousficolin-2or ficolin-A (aficolin-2-like molecule in mouse), with only once, could remarkably inhibit the tumorcellsgrowth in murine tumor models via earlymacrophages, dendriticcells(DCs) andCD8+Tcells, but not CD4+Tcells. Ficolin-A (FCN-A) knockout (KO) mice exhibits significantly increased tumor cell growth.Ficolin-2induces macrophage activation, promotes M1 polarization and facilitates proliferation and antigen-specific cytotoxicity ofCD8+Tcells.Ficolin-2binds to Toll-like receptor 4 (TLR4) onmacrophagesand DCs and promotes their antigen-presenting abilities toCD8+Tcells. Our findings provide a new therapeutic strategy for tumors based on the triggering of immune-mediatedantitumoreffectbyficolin-2.

KEYWORDS:

Antitumoreffect;CD8(+)T; Dendriticcells(DCs);Ficolin-2/A; Macrophage

Tel: 0086-27-68750205 Fax: 0086-27-68759675  Email: mri@whu.edu.cn

Contact address: Donghu Road, No. 115, Wuchang District, Wuhan, Hubei Province, P.R. China. 430071

Copyright @ 2016 Medical Research Institute

XML 地图 | Sitemap 地图